Articles tagged "Kidney transplantation"

2015 American Transplant Congress
Kidneys from Living Donors With High Body Mass Index Do Not Have Inferior Outcomes
K. Koutroutsos, S. Chong, D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, D. Taube, M. Loucaidou.
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The disparity between donor kidney availability and demand has increased utilization of kidneys from marginal living donors. Data regarding outcome of transplantation from living donors…
2015 American Transplant Congress
Education and Employment After Renal Transplantation in Young Adults: An International Study
J. Gralla,¹ P. Murray,² A. Wiseman,¹ P. Harden.³
¹Transplant Center, University of Colorado Denver, Aurora, CO; ²Newcastle University, Newcastle Upon Tyne, United Kingdom; ³Oxford Kidney Unit and Transplant Centre, Oxford, United Kingdom.
Purpose: Young adults who have received a kidney transplantation (KT) have significant obstacles in achieving educational goals and finding employment. The purpose of this study…
2015 American Transplant Congress
Vaccine Responses in Combined Hematopoeitic Stem Cell-Kidney Transplant Recipients
C. Feng,¹ M. Ison,¹ J. Galvin,¹ S. Ildstad,^2,3 D. Stare,¹ J. Leventhal.¹
¹Northwestern University, Chicago, IL; ²University of Louisville, Louisville, KY; ³Regenerex, LLC, Louisville, KY.
Background: Vaccines remain one of the most effective methods of preventing infections following transplantation. Data suggests that vaccine responses are reduced in recipients of hematopoeitic…
2015 American Transplant Congress
Operational Tolerance in Kidney Transplantation: Results of a Europe-Wide Survey
A. Massart,¹ A. Pallier,² O. Viklicky,^3,4 J. Pascual,^3,5 K. Budde,^3,6 S. Sorensen,^3,7 R. Oberbauer,^3,8 M. Klinger,^3,9 C. Dudley,^3,10 M. Sever,^3,11 G. Spasovski,^3,13 P. Guérif,² U. Maggiore,^3,12 M. Abramowicz,¹ M. Giral,² D. Abramowicz,¹⁴ S. Brouard.²
¹Erasme, Brussels, Belgium; ²Nantes University, Nantes, France; ³ERA-EDTA-DESCARTES Working Group, Parma, Italy; ⁴IKEM, Prague, Czech Republic; ⁵Hospital del Mar, Barcelona, Spain; ⁶CCM, Berlin, Germany; ⁷Rigshospitalet, Copenhagen, Denmark; ⁸KH Elisabethinen, Linz, Austria; ⁹WMU, Wrocław, Poland; ¹⁰NBT, Bristol, United Kingdom; ¹¹IMSSC, Istanbul, Turkey; ¹²Ospedale Maggiore, Parma, Italy; ¹³UCC, Skopje, Macedonia, The Former Yugoslav Republic of; ¹⁴UZA, Antwerpen, Belgium.
BACKGROUND: Operational Tolerance (opTOL) is deemed to be extremely rare in kidney transplantation. We launched a Europe-wide survey to assess the frequency of opTOL.METHODS: 18…
2015 American Transplant Congress
Outcomes of Post-Kidney Transplant Leukemias
B. Rouphael, A. Kukla, K. Gillingham, H. Ibrahim, A. Matas, N. Issa.
Medicine, University of Minnesota, Minneapolis, MN.
Background:Leukemias typically portend bad prognosis in the general population. The incidence and outcomes of post-kidney transplant leukemias (PKTL) have not been well studied as most…
2015 American Transplant Congress
Comparative Survival Benefits and Costs of an Eplet and Broad Antigen Based Matching System in Deceased Donor Kidney Transplant Allocation Among Indigenous Australians
H. Do Nguyen,¹ G. Wong,^2,3 J. Chapman,² J. Craig,^2,3 L. D'Orsogna,⁴ W. Lim.^1,5
¹School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; ²Nephrology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia; ³School of Medicine, University of New South Wales, Sydney, New South Wales, Australia; ⁴Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia; ⁵Renal Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Aim: To compare the benefits and costs of incorporating an eplet-based matching algorithm to the current allocation of deceased donor kidneys to indigenous Australians.Background: The…
2015 American Transplant Congress
Explorative Analysis of ZEUS After 5 Years: Histological Assessment from Biopsy Analyses
U. Eisenberger,¹ K. Budde,¹ O. Witzke,¹ F. Lehner,¹ C. Sommerer,¹ R. Wuethrich,³ P. Reinke,¹ A. Muehlfeld,¹ K. Heller,¹ R. Stahl,¹ H. Wolters,¹ I. Hauser,¹ M. Porstner,² W. Arns.¹
¹ZEUS Study Group, Germany; ²Novartis, Pharma, Germany; ³ZEUS Study Group, Switzerland.
Background: Analysis of pathologists' assessments and histological data allow for deeper insight on patient outcome together with investigator's final clinical diagnoses. Here we present 5…
2015 American Transplant Congress
Calcineurin Inhibitors (CNI) Minimization Associated With Mammalian Target of Rapamycin Inhibitors (i-mTOR) to Improve Renal Function in Renal Grafts from Uncontrolled Donation After Cardiac Death Donors (UDCDD)
M. Molina,¹ E. Gutierrez,¹ S. González-Sanchidrian,² E. González,¹ J. Cabrera,¹ N. Polanco,¹ A. Hernández,¹ A. Sevillano,¹ M. Praga,¹ A. Andres.¹
¹Nephrology, Hospital 12 de Octubre, Madrid, Spain; ²Nephrology, Hospital San Pedro de Alcántara, Caceres, Spain.
INTRODUCTION: Ischemia injury in kidneys grafts from UDCDD could produce a poor renal function. Minimized blood levels of CNI associated with i-mTOR therapy could avoid…
2015 American Transplant Congress
The Clinical Outcome of Plasma Cell-Rich Rejection of Kidney Allograft
J. Hasegawa,¹ K. Honda,² S. Wakai,¹ H. Shirakawa,³ M. Okumi,³ K. Omoto,³ H. Ishida,³ K. Tanabe.³
¹Nephrology, Ohkubo Hospital, Tokyo, Japan; ²Pathology, Tokyo Women's Medical University, Tokyo, Japan; ³Urology, Tokyo Women's Medical University, Tokyo, Japan.
Background: Plasma cell-rich rejection (PCRR) is a rare type of allograft rejection characterized by the presence of mature plasma cells. This type of rejection has…
2015 American Transplant Congress
Living Donor Transplant Rates in Children Are Declining
D. Keith, A. Nishio Lucar, G. Vranic.
University of Virginia, Charlottesville, VA.
Living donor (LD) transplant rates have been declining since 2004 in adult candidates. We sought to determine if this trend is also occurring in pediatric…